Does Omeprazole Deplete Calcium? What the Research Says

Yes, omeprazole depletes calcium through impaired intestinal absorption — and the FDA took this seriously enough to issue a formal safety communication in 2011 warning that long-term PPI use increases hip, wrist, and spine fracture risk. CTD's molecular database documents 395 randomized controlled trials involving 360,638 patients studying omeprazole's effects, with 52 meta-analyses synthesizing outcomes. PubMed indexes 4,642 articles on omeprazole. The calcium depletion mechanism is indirect but potent: by suppressing gastric acid by up to 90%, omeprazole prevents the solubilization of calcium salts in the stomach that is necessary for downstream intestinal absorption. Calcium biomarker data sets the optimal range at 9.0-10.2 mg/dL versus the standard lab range of 8.5-10.5 mg/dL. The clinical significance escalates with duration — fracture risk increases meaningfully after 1 year of continuous PPI therapy and continues climbing with each additional year.

The evidence linking omeprazole to calcium depletion and fracture risk comes from multiple large epidemiological studies and meta-analyses. On the calcium side, CTD documents 2,665 randomized controlled trials across 4,621,238 patients studying calcium's biological roles, with PubMed indexing 89,242 articles — reflecting calcium's fundamental importance in bone health, nerve signaling, and cardiac function. FAERS adverse event monitoring for omeprazole captures fracture reports at rates significantly higher than background population rates, particularly in postmenopausal women and elderly patients on chronic PPI therapy. Multiple population-based studies found that PPI use for more than 1 year was associated with 25-60% increased hip fracture risk compared to non-users. The dose-response relationship is consistent: higher PPI doses and longer durations produce greater fracture risk increases. Serum calcium levels may appear normal because parathyroid hormone compensates by pulling calcium from bones — meaning the skeleton pays the price while blood levels stay deceptively stable.

Omeprazole depletes calcium through gastric acid suppression that impairs calcium solubilization. Calcium in food and most supplements exists as insoluble salts (particularly calcium carbonate, the most common supplement form) that require an acidic environment to dissolve into absorbable ionic calcium. When omeprazole suppresses gastric acid by up to 90%, calcium carbonate remains largely insoluble and passes through the GI tract unabsorbed. The effect is most dramatic for calcium carbonate (which absolutely requires acid) and less severe for calcium citrate (which dissolves independent of pH). Beyond direct absorption, chronic acid suppression may also impair calcium absorption through secondary effects on vitamin D metabolism and parathyroid hormone regulation. The parathyroid gland compensates for reduced calcium absorption by increasing PTH secretion, which pulls calcium from bones to maintain blood levels. This skeletal calcium mobilization — invisible on routine blood tests — progressively weakens bone architecture over months and years.

For omeprazole use exceeding 1 year, switch calcium supplements from calcium carbonate to calcium citrate, which does not require stomach acid for absorption. Target 1,000-1,200 mg of elemental calcium daily from combined dietary and supplement sources. Split doses into 500-600 mg servings since absorption capacity is limited per serving. Pair calcium with 2,000-4,000 IU of vitamin D3 daily to maximize intestinal calcium absorption through vitamin D-dependent transport proteins. Monitor serum calcium (target 9.0-10.2 mg/dL), PTH, and 25-hydroxyvitamin D annually. Note that normal serum calcium does not rule out bone calcium depletion — if you have been on omeprazole for more than 2 years, discuss bone density testing (DEXA scan) with your provider. Prioritize calcium-rich foods that do not depend on gastric acid: dairy products (where calcium is already partially solubilized), sardines with bones, and fortified plant milks. Discuss with your provider whether stepping down to an H2 blocker or intermittent PPI dosing could reduce calcium absorption interference.